Clinician, researcher, educator to maintain Dana-Farber, Harvard
positions while helping global breast cancer leader attain strategic
Eric Winer, MD
DALLAS — Susan G. Komen for the Cure, the world's
largest grassroots network of breast cancer survivors and activists, has
announced the appointment of Eric P. Winer, MD, a nationally known
medical oncologist, researcher and educator from the Dana-Farber Cancer
Institute and Harvard Medical Center, as its chief scientific advisor.
In announcing Winer's appointment, Komen for the Cure's founder,
Nancy G. Brinker, said, "Dr. Eric Winer brings the perfect balance of
research, clinical, educational and administrative skills to Komen and
its Health Sciences team. The breast cancer world listens to Eric. He is
a leader, a brilliant idea person and a gifted clinician, recognized as
a role model and guide for coming generations of doctors and
researchers. Most importantly, he is deeply devoted to new and better
treatments for breast cancer patients."
As he assumes the role of Komen's chief scientific advisor, Winer
will maintain his positions as director of the Breast Oncology Center at
Dana-Farber. In addition to his duties at Dana-Farber, Winer will
retain his position of associate professor of medicine at Harvard
Medical School in Boston.
Winer comes to Komen as the organization embarks on a mission to
invest another $1 billion over the next decade in breast cancer research
and community outreach programs that will move the organization closer
to its promise to end breast cancer forever. In recent weeks, Komen
announced nearly $82 million dollars in scientific research grants last
fiscal year, an increase of 40 percent over the previous year.
Helping to fulfill the Komen promise
"Susan G. Komen for the Cure is committed to helping patients with
breast cancer today and eliminating the fear of breast cancer for future
generations," said Winer. "With a renewed promise to end breast cancer
forever, I'm very enthusiastic about joining the Komen team. I'm
bringing with me the insight I've gained from 20 years in working in
breast cancer, the last 10 of which have been at Dana-Farber Cancer
Institute and Harvard Medical School."
As Komen's chief scientific advisor, Winer will advise the
organization on its grants strategy and help plan public policy efforts.
He will also advise the organization on the development of new
educational messages, assist in shaping organizational responses to
emerging breast cancer news and serve as a global spokesperson for
Komen. Winer also will help create a small group of top-level scientific
and medical advisors that will guide Komen over the years ahead.
Winer is widely published and well known in the international breast
cancer community. His research interests stem directly from considerable
experience in the clinical arena and the challenges that have been
posed by more than 2,000 breast cancer patients he has cared for
throughout his career. His primary research focus is on improving the
lives of women with breast cancer by understanding the intricacies of
the disease process and developing more effective and less toxic
treatments. He is a devoted educator, with an ongoing interest in
training and mentoring the next generation of clinicians and
After graduating from Yale University in 1978 with a degree in
history and Russian/East European studies, Winer earned his medical
degree from Yale School of Medicine in 1983, followed by training in
internal medicine at Yale. He moved to Duke University Medical Center in
1987 and completed a fellowship in medical oncology in 1989. On the
Duke faculty, he specialized in breast cancer and became co-director of
the institution's Multidisciplinary Breast Program. In 1997, Winer moved
to Dana-Farber Cancer Institute, where he became director of the Breast
Oncology Center and associate professor of medicine at Harvard Medical
Winer is the co-chair of the breast cancer committee in the Cancer
and Leukemia Group B (CALGB) and has had wide-ranging experience in
numerous national and international breast cancer initiatives.
About Susan G. Komen for the Cure
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would
do everything in her power to end breast cancer forever. In 1982, that
promise became Susan G. Komen for the Cure and launched the global
breast cancer movement. Today, Komen for the Cure is the world's largest
grassroots network of breast cancer survivors and activists fighting to
save lives, empower people, ensure quality care for all and energize
science to find the cures. Thanks to events like the Komen Race for the
Cure, we have invested nearly $1 billion to fulfill our promise,
becoming the largest source of nonprofit funds dedicated to the fight
against breast cancer in the world. For more information about Susan G.
Komen for the Cure, breast health or breast cancer, visit www.komen.org or call 1-800 I'M AWARE.